Who's Who
Magali Olivier
Scientist
Molecular Mechanisms and Biomarkers Group
Specialty:
Molecular biology and epidemiology of cancer, molecular databasesAcademic Degrees
| Year | Degree | Major | Institution | Town | Country |
|---|---|---|---|---|---|
| 1998 | PhD | Molecular and cellular biology of cancer | University of Montpellier | Montpellier | France |
| 1993 | DEA | Biochemistry & Health | University of Montpellier | Montpellier | France |
| 1992 | Maitrise | Biochemistry | University of Nice Sofia-Antipolis | Nice | France |
| 1991 | Licence | Biochemistry | University of Nice Sofia-Antipolis | Nice | France |
| 1990 | DEUG | Biology | University of Nice Sofia-Antipolis | Nice | France |
Current Research Projects
- Functional genomics of breast cancer
- IARC TP53 database (www-p53.iarc.fr)
- Biomarkers in lung cancer from non-smokers
Selected Publications
Fernández-Cuesta L, Oakman C, Falagan-Lotsch P, Smoth K, Quinaux E, Buyse M, Dolci MS, De Azambuja E, Hainaut P, Dell'Orto P, Larsimont D, Francis PA, Crown J, Piccart-Gebhart M, Viale G, Di Leo A, and Olivier M. (2012) Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane based adjuvant therapy: results from the BIG 02-98 phase III trial Breast Cancer Res, In pressScoccianti C, Vesin A, Martel G, Olivier M, Brambilla E, Timsit JF; the EUELC Consortium, Tavecchio L, Brambilla C, Field JK, Hainaut P. (2012) Prognostic value of TP53, KRAS and EGFR mutations in Non-Small Cell Lung Cancer: EUELC cohort Eur Respir, In press
Fernandez-Cuesta L, Anaganti S, Hainaut P, Olivier M. (2011) p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines Int J Cancer : 1813-21
Anaganti S, Fernandez-Cuesta L, Langerød A, Hainaut P, Olivier M. (2011) p53-dependent repression of Focal Adhesion Kinase in response to estradiol in breast cancer cell-lines Cancer Letters : 215-24
Fernández-Cuesta L, Anaganti S, Hainaut P, Olivier M. (2011) Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines. Breast Cancer Res Treat. Vol 125 : 35-42
Scientific Societies Membership
European Association for Cancer ResearchPrizes, Honours
Exchange Visit Grant in Frontiers of Functional Genomics, ESF, 2011Research Fellowship, Fondation pour la Recherche Médicale, 1997
Research fellowship, French Government, 1994-1996

